Innate Pharma
IPHA
$2.31
Share price
-6.85%
Change (1 day)
-21.69%
Change (1 year)
Categories
Operating Margin for Innate Pharma (IPHA)
Operating Margin at the end of 2021: -375.54%
According to Innate Pharma 's latest financial reports and stock price the company's current Operating Margin is -375.54%. At the end of 2021 the company had an Operating Margin of -375.54%.
Operating Margin history for Innate Pharma from 2005 to 2021
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -375.54% | 233.57% |
| 2020 | -112.58% | 274.06% |
| 2019 | -30.10% | -984.67% |
| 2018 | 3.40% | -102.31% |
| 2017 | -147.15% | -738.58% |
| 2016 | 23.04% | -161.53% |
| 2015 | -37.45% | -98.27% |
| 2014 | -2,166.15% | 9239.47% |
| 2013 | -23.19% | -24.76% |
| 2012 | -30.83% | -48.15% |
| 2011 | -59.45% | -81.19% |
| 2010 | -316.16% | 66.79% |
| 2009 | -189.55% | 148.66% |
| 2008 | -76.23% | 22.15% |
| 2007 | -62.41% | -36.01% |
| 2006 | -97.53% | -79.31% |
| 2005 | -471.46% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.